|
|
|||
|
|
||
|
|||
|
Ozgene Pty, Ltd. is a leading Australian biotech company, based in Perth, which produces genetically modified (GM) mice and rats for use in Functional Genomics and Drug Target Validation studies in Research Institutes, Biotechnology and Multinational Pharmaceutical Companies worldwide. Ozgene provides a complete vector design and vector construction service followed by the generation of classical or conditional knockouts, knockins, transgenics and lentiviral transgenics. They also offer phenotypic analysis of GM mice, providing a complete service from gene discovery to gene function. The GM mice produced by Ozgene provide researchers with good animal models that mimic human genetic disorders on a molecular level. Ozgene recently added a Multichannel Biomek NX to their existing liquid handling capabilities and now boasts both a Biomek FX and a Biomek NX. The systems are used for genomic and plasmid DNA preparations, sequence setup and cleanup, PCR setup and embryonic stem cell culture. Innovation is a key part of the Ozgene culture; their new Biomek NX is housed in a HEPA filtered isolator to allow the automation of tissue culture procedures under sterile conditions (see attached photo). To understand more about the great service offered by Ozgene, visit their website at www.ozgene.com
Additional Information: For comments or questions about T3 Update, please contact David Daniels, Ph.D., editor.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
